Vai ai contenuti. | Spostati sulla navigazione | Spostati sulla ricerca | Vai al menu | Contatti | Accessibilità

logo del sistema bibliotecario dell'ateneo di padova

Riccadonna, Cristina (2010) Peripheral immune status in the GFAP-V12 HA-ras B8 spontaneous astrocytoma model. [Magistrali biennali]

Full text disponibile come:



In questo lavoro sperimentale, è stata in particolare studiata l’interazione tra tumore e sistema immunitario.

Item Type:Magistrali biennali
Uncontrolled Keywords:Immunosoppressione, Tumor immunology
Subjects:Area 06 - Scienze mediche > MED/04 Patologia generale
Codice ID:26707
Relatore:De Bernard, Marina
Data della tesi:2010
Biblioteca:Polo di Scienze > CIS "A. Vallisneri" - Biblioteca Biologico Medica
Tipo di fruizione per il documento:on-line per i full-text
Tesi sperimentale (Si) o compilativa (No)?:Yes


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione e non da noi.

Okezie O. Kanu, Ankit Mehta, Chunhui Di, Ningjing Lin, Kathy Bortoff, Darell D. Bigner, Hai Yan and David Cory Adamson; Glioblastoma multiforme: a review of therapeutic targets; Expert Opinion on Therapeutic Targets (2009), 13(6):701-718. Cerca con Google

David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler, Webster K. Cavenee, Peter C. Burger, Anne Jouvet, Bernd W. Scheithauer and Paul Kleihue; The 2007 WHO Classification of Tumours of the Central Nervous System; Acta Neuropathologica (2007), 114:97–109. Cerca con Google

Patrick Y. Wen and Santosh Kesari; Malignant glioma in adults; The New England Journal of Medicine (2009), 359:492-507. Cerca con Google

Nienke A. De Vries, Jos H. Beijnen and Olaf van Tellingen; High-grade glioma mouse models and their applicability for preclinical testing; Cancer Treatment Review (2009), 35(8):714-723. Cerca con Google

Angelo L. Vescovi, Rossella Galli and Brent A. Reynolds; Brain tumour stem cells; Nature Reviews Cancer (2006), 6:425-436. Cerca con Google

Virginie Clément, Valérie Dutoit, Denis Marino, Pierre-Yves Dietrich and Ivan Radovanovic; Limits of CD133 as a marker of glioma self-renewing cells; International Journal of Cancer (2009), 125:244–248. Cerca con Google

Roger Stupp, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG and Mirimanoff RO; Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trail; The Lancet Oncology (2009), 10:459-66. Cerca con Google

Hiroko Ohgaki and Paul Kleihues; Genetic alterations and signaling pathways in the evolution of glioma; Cancer Sci (2009), 100(12):2235-41. 71 Cerca con Google

Ramon Martinez and Manel Esteller; The DNA methylome of glioblastoma multiforme; Neurobiology of Disease (2010), 39(1):40-46. Cerca con Google

Diana Munoz, Sameer Agnihotri and Abhijit Guha; Transgenic mouse models of CNS tumors: using genetically engineered murine models to study the role of p21-Ras in glioblastoma multiforme; CNS cancer (2009), Humana Press, 61-76. Cerca con Google

Tao Xu, Juxiang Chen, Yicheng Lu and Johannes EA Wolff; Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis; BMC Cancer (2010), 10:252. Cerca con Google

Jeremy B. Swann and Mark J. Smyth; Immune surveillance of tumors; The Journal of Clinical Investigation (2007), 117(5):1137–1146. Cerca con Google

Jack D. Bui and Robert D. Schreiber; Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?; Current Opinion in Immunology (2007), 19(2):203-208. Cerca con Google

Monica J. Carson, Jonathan M. Doose, Benoit Melchior, Christoph D. Schmid and Corinne C. Ploix; CNS immune privilege: hiding in plain sight; Immunological Reviews (2006), 213:48–65. Cerca con Google

Oliver M. Grauer, Pieter Wesseling and Gosse J. Adema; Immunotherapy of diffuse glioma: biological background, current status and future developments; Brain Pathology (2009), 19:674-693. Cerca con Google

Paul R. Walker, Robert M. Prins, Pierre-Yves Dietrich and Linda M. Liau; Harnessing T-cell immunity to target brain tumors; CNS Cancer (2009), Humana Press, 1165-1217. Cerca con Google

Hideho Okada, Gary Kohanbash, Xinmei Zhu, Edward R. Kastenhuber, Aki Hoji, Ryo Ueda and Mitsugu Fujita; Immunotherapeutic approaches for glioma; Critical Reviews in Immunology (2009), 29(1):1–42. Cerca con Google

Robert M. Prins and Linda M. Liau; Cellular immunity and immunotherapy of brain tumors; Frontiers in Bioscience (2004), 9:3124-3136. 72 Cerca con Google

Eric J. Kunkel and Eugene C. Butcher; Chemokines and the tissue-specific migration of lymphocytes; Immunity (2002), 16:1–4. Cerca con Google

Peter Parham; The immune system (2009), Third Edition, Garland Science. Cerca con Google

Thomas Calzascia, Frédérick Masson, Wilma Di Berardino-Besson, Emmanuel Contassot, Rick Wilmotte, Michel Aurrand-Lions, Curzio Rüegg Pierre-Yves Dietrich and Paul R. Walker; Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs; Immunity (2005), 22:175–184. Cerca con Google

Frédérick Masson, Thomas Calzascia, Wilma Di Berardino-Besson, Nicolas de Tribolet, Pierre-Yves Dietrich and Paul R. Walker; Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells; The Journal of Immunology (2007), 179:845-853. Cerca con Google

Xuefang Cao; Regulatory T cells and immune tolerance to tumors; Immunologic Research (2010), 46:79-93. Cerca con Google

Nhu Nam Tran Thang, Madiha Derouazi, Géraldine Philippin, Séverine Arcidiaco,Wilma Di Berardino-Besson, Frédérick Masson, Sabine Hoepner, Cristina Riccadonna, Karim Burkhardt, Abhijit Guha, Pierre-Yves Dietrich and Paul R. Walker; Immune infiltration of spontaneous mouse astrocytoma is dominated by immunosuppressive cells from early stages of tumor development; Cancer Research (2010), 70(12):4829-39. Cerca con Google

Paul R. Walker, Thomas Calzascia and Pierre-Yves Dietrich; All in the head: obstacles for immune rejection of brain tumours; Immunology (2002), 107:28–38. Cerca con Google

Amy R. Dix, William H. Brooks, Thomas L. Roszman and Lorri A. Morford; Immune defects observed in patients with primary malignant brain tumors; Journal of Neuroimmunology (1999), 100:216-232. Cerca con Google

Peter E. Fecci, Duane A. Mitchell, John F. Whitesides, Weihua Xie, Allan H. Friedman, Gary E. Archer, James E. Herndon, Darell D. Bigner, Glenn Dranoff and John H. Sampson; Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma; Cancer Research (2006), 66:3294-3302. 73 Cerca con Google

Allen Waziri; Glioblastoma-derived mechanisms of systemic immunosuppression; Neurosurgery Clinics of North America (2010), 21:31-42. Cerca con Google

Lorri A. Morford, Lucinda H. Elliott, Sonia L. Carlson, William H. Brooks and Thomas L. Roszman; T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors; The Journal of Immunology (1997), 159:4415-4425. Cerca con Google

Patrick Shannon, Nesrin Sabha, Nelson Lau, Deepak Kamnasaran, David H. Gutmann and Abhijit Guha; Pathological and molecular progression of astrocytoma in a GFAP:12V-Ha-ras mouse astrocytoma model; American Journal of Pathology (2005), 167:859-867. Cerca con Google

Hao Ding, Luba Roncari, Patrick Shannon, Xiaoli Wu, Nelson Lau, Jana Karaskova, David H. Gutmann, Jeremy A. Squire, Andras Nagy and Abhijit Guha; Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human glioma; Cancer Research (2001), 61:3826-3836. Cerca con Google

Koji Tokoyoda, Sandra Zehentmeier, Ahmed N. Hegazy, Inka Albrecht, Joachim R. Grün, Max Löhning and Andreas Radbruch; Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow; Immunity (2009), 30:721-730. Cerca con Google

Theresa L. Walunas, David S. Bruce, Lynn Dustin, Dennis Y. Lob and Jeffrey A. Bluestone; Ly-6C is a marker of memory CD8+ T cells; The journal of Immunology (1995), 155:1873-1883. Cerca con Google

Je-In Youn, Srinivas Nagaraj, Michelle Collazo and Dmitry I. Gabrilovich; Subsets of myeloid-derived suppressor cells in tumor-bearing mice; The journal of Immunology (2008), 181:5791-5802. Cerca con Google

Laurie E. Harrington, Robbert van der Most, J. Lindsay Whitton and Rafi Ahmed; Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope; Journal of Virology (2002), 76:3329–3337. Cerca con Google

Solo per lo Staff dell Archivio: Modifica questo record